CBD is an acronym for cannabidiol. It is a non-cannabimimetic, naturally occurring, non-psychoactive cannabis constituent that is believed to have neuropsychological benefits. It was first identified in 1940 when it was discovered that the psychoactive component of cannabis is cannabidiol. It accounts for over 40% of the active component of cannabis plants and is one of the strongest of the known cannabinoids. It has been used to treat several forms of epilepsy and is also being investigated for its use in treating depression, anxiety, and schizophrenia.You may want to check out Rowlett CBD Association for more.
A recent study in Spain showed that patients with chronic forms of Alzheimer’s disease had a significantly increased rate of improvement compared to healthy people who were taking a placebo. The reason for this was because CBD prevented neuroinflammation which is associated with Alzheimer’s disease. In an attempt to understand how CBD is able to block inflammation, Dr. Marco Valli, a psychiatrist at the University of Milan in Italy, and his team conducted a series of laboratory tests on mice that were genetically engineered to produce inflammatory molecules, namely TNF and IL-6, which are involved in inflammation of the brain.
They discovered that CBD prevented neuroinflammation, which was responsible for the mice’s inability to form new memories. CBD was found to be particularly effective against the inflammatory molecules TNF and IL-6. When Valli and his team administered the same amount of CBD to the mice, they learned to associate specific locations and tones with certain locations on their maze. In other words, they learned how to find their home, regardless of where they’d initially entered the maze. This is important information, as it suggests that CBD may be effective in treating a variety of psychological problems related to depression, such as dementia, Alzheimer’s, and schizophrenia.